Cascadian Therapeutics
Bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
Employees
Enterprise value
$614m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
$614m Valuation: $614m | Acquisition | ||
| Total Funding | 000k | ||
NEA(exited)
Cowen Group(exited)
Straus Partners(exited)
Ayer Capital Management(exited)
Iroquois Capital an Incorporated(exited)
Dafna Capital Management(exited)
BVF Partners(exited)
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.